Kimberly Blumenthal, MD, MSc, is an allergist/immunologist and drug allergy researcher at Massachusetts General Hospital and assistant professor of Medicine at Harvard Medical School. She is the co-director of the Clinical Epidemiology Program within the Division of Rheumatology Allergy and Immunology and director of research for the Drug and Vaccine Allergy Center. Dr. Blumenthal performs drug allergy research that uses methods of epidemiology, informatics, economics and decision science. Her research is funded by the NIH/NIAID, AHRQ and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation. Dr. Blumenthal is recognized nationally for having identified the morbidity and mortality associated with unverified penicillin allergy labels and creating innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in the hospital setting. Dr. Blumenthal has authored more than 60 peer-reviewed publications including manuscripts published in high-impact journals such as Lancet, JAMA, and the BMJ.
Dr. Blumenthal graduated from Columbia University with a BA in Economics. She studied medicine at Yale University School of Medicine, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.